US Patent Issued to UNIVERSITE DE MONTREAL on April 29 for "Heterocyclic mitochondrial activity inhibitors and uses thereof" (Canadian, French Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,426, issued on April 29, was assigned to UNIVERSITE DE MONTREAL (Montreal, Canada).

"Heterocyclic mitochondrial activity inhibitors and uses thereof" was invented by Yves Gareau (Notre-Dame-de-I'lle-Perrot, Canada), Stephane Gingras (Montreal, Canada), Yves Chantigny (Pincourt, Canada), Gaoqiang Yang (Montreal), Guy Sauvageau (Montreal, Canada), Irene Baccelli (Nantes, France) and Anne Marinier (Kirkland, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Heterocyclic compounds of Formula I:and pharmaceutically acceptable salt thereof are disclosed. The use of such heterocyclic compounds and pharmaceutically acceptable salt thereof for the treatme...